journal article·2018-08-08

Supramolecular Modular Approach toward Conveniently Constructing and Multifunctioning a pH/Redox Dual-Responsive Drug Delivery Nanoplatform for Improved Cancer Chemotherapy

Jia Liu, Xingxin Liu, Ye Yuan, Qilin Li, Bingcheng Chang, Luming Xu, Bo Cai, Chao Qi, Cao Li, Xulin Jiang, Guobin Wang, Zheng Wang, Lin Wang

ACS Applied Materials & Interfaces· Volume 10· Issue 31
Publisher page

Abstract

Because heterogeneity affects many functional aspects of a tumor, a way to overcome it is to arm nanosized drug delivery systems (nanoDDS) with diverse functions required to shatter heterogeneity. However, it remains technically challenging to fabricate a nanocarrier possessing all required functions. Here, we propose a modular strategy for generating a supramolecular, multifunctional, and stimuli-responsive nanoDDS through docking a parental core nanoDDS with various daughter function-prebuilt modules. Doxorubicin (DOX)-loaded mesoporous silica nanoparticles (MSNs) as the parental nanocore are wrapped by poly(β-cyclodextrin) (PCD) as a gatekeeper through host-guest interactions between cyclodextrin units and pyridine groups of pyridine-disulfide bonds that confers pH/redox dual responsiveness, thus constructing stimuli-responsive nanoDDS (DOX@PRMSNs). Meanwhile, PCD's free cyclodextrin is tightly caged by adamantyl (Ad)-terminated daughter modules via host-guest interactions, achieving convenient multifunctionalization of this nanoDDS. DOX@PRMSNs rapidly released DOX in lysosomal pH/redox microenvironment, potently killing drug-resistant cancer cells. Further, three different types of Ad-terminated daughter modules, including two targeting ligands (Ad-PEG-FA and Ad-PEG-LA), a cationic polymer (Ad-PEI), and a fluorescence agent (Ad-FITC), are utilized to functionalize PRMSNs via cyclodextrin-Ad self-assembly, endowing the nanoDDS with cell-targeting capability, gene codelivery property, and imaging function. Thus, this work develops a supramolecular modular self-assembly approach for constructing and multifunctionalizing stimuli-responsive "smart" nanoDDSs.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · Supramolecular Chemistry and Complexes

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Hubei Collaborative Innovation Center for Advanced Organic Chemical Materials, Key Laboratory for the Green Preparation and Application of Functional, Materials of Ministry of Education, Hubei University, Wuhan 430062, China

Key Laboratory of Biomedical Polymers of Ministry of Education and Department of Chemistry, Wuhan University, Wuhan 430072, China

Funding

Ministry of Education of the People's Republic of China · Ministry of Science and Technology of the People's Republic of China · Ministry of Health of the People's Republic of China · Huazhong University of Science and Technology · Natural Science Foundation of Hubei Province · National Natural Science Foundation of China · Tongji Medical College, Huazhong University of Science and Technology

References (37)

Show source-provided references
1. 10.1038/nrclinonc.2017.16610.1038/nrclinonc.2017.166 ↗
2. 10.1038/nature1262610.1038/nature12626 ↗
3. 10.1038/embor.2013.9210.1038/embor.2013.92 ↗
4. 10.1038/s41565-017-0043-510.1038/s41565-017-0043-5 ↗
5. 10.1038/nrc326110.1038/nrc3261 ↗
6. 10.1038/nrclinonc.2016.17110.1038/nrclinonc.2016.171 ↗
7. 10.1016/j.addr.2015.12.00210.1016/j.addr.2015.12.002 ↗
8. 10.1002/adma.20160662810.1002/adma.201606628 ↗
9. 10.1038/nmat377610.1038/nmat3776 ↗
10. 10.1038/natrevmats.2016.7510.1038/natrevmats.2016.75 ↗
11. 10.1038/nrd259110.1038/nrd2591 ↗
12. 10.1038/nrd451910.1038/nrd4519 ↗
13. 10.1016/j.biotechadv.2014.05.00610.1016/j.biotechadv.2014.05.006 ↗
14. 10.1016/j.biomaterials.2015.09.03710.1016/j.biomaterials.2015.09.037 ↗
15. 10.1021/acs.chemrev.5b0032110.1021/acs.chemrev.5b00321 ↗
16. 10.1021/acs.chemrev.6b0007310.1021/acs.chemrev.6b00073 ↗
17. 10.1021/cm402592t10.1021/cm402592t ↗
18. 10.1002/adma.20110476310.1002/adma.201104763 ↗
19. 10.1021/acs.bioconjchem.6b0009410.1021/acs.bioconjchem.6b00094 ↗
20. 10.1039/c6tb01671e10.1039/c6tb01671e ↗
21. 10.1039/c3cc48098d10.1039/c3cc48098d ↗
22. 10.1002/smll.20160256710.1002/smll.201602567 ↗
23. 10.1021/ja01500a00810.1021/ja01500a008 ↗
24. 10.1002/adma.20140508410.1002/adma.201405084 ↗
25. 10.1016/j.bbrc.2007.12.16810.1016/j.bbrc.2007.12.168 ↗
26. Griffith O. W. · J. Biol. Chem. · 1979 · 254 · 755810.1016/S0021-9258(18)35980-5 ↗
27. 10.2174/09298670978880331210.2174/092986709788803312 ↗
28. 10.1021/mp070024d10.1021/mp070024d ↗
29. 10.1016/j.addr.2013.09.01910.1016/j.addr.2013.09.019 ↗
30. 10.1038/nrc.2016.10810.1038/nrc.2016.108 ↗
31. 10.1016/j.jconrel.2015.02.02210.1016/j.jconrel.2015.02.022 ↗
32. 10.1021/ac401377n10.1021/ac401377n ↗
33. 10.1016/j.addr.2015.10.01410.1016/j.addr.2015.10.014 ↗
34. 10.1016/j.addr.2015.10.01910.1016/j.addr.2015.10.019 ↗
35. 10.1002/smll.20130395110.1002/smll.201303951 ↗
36. Nimesh, S. Gene Therapy; Woodhead Publishing, 2013; Chapter 10, pp 197–223.10.1533/9781908818645.197 ↗
37. 10.1021/acs.chemrev.5b0014810.1021/acs.chemrev.5b00148 ↗